Cosmos Health Inc. (NASDAQ: COSM) announced on July 27, 2026, the active development of a flexible, technology-driven subscription platform for its consumer health products, marking a significant step in its broader technology transformation. The platform is designed to generate predictable, recurring revenue by serving both business-to-consumer (B2C) and business-to-business (B2B) channels with personalized health packages. This move addresses the company’s strategic goal of building a scalable, technology-enabled revenue stream that creates long-term value for shareholders.

The platform offers customers three entry paths: a free consultation with a nutritionist, engagement with an AI-powered assistant, or the ability to build their own package. Based on individual health and wellness goals, the system assembles personalized packages consisting primarily of Cosmos Health’s proprietary products, supplemented by third-party items where necessary. Future enhancements are expected to include deeper AI-driven personalization and the potential integration of at-home testing and diagnostic kits to inform subscriptions with individualized health insights.

Platform Features and Business Models

The subscription service supports multiple purchasing models tailored to different customer segments. Key features include:

Greg Siokas, CEO of Cosmos Health, stated, "We are building a subscription platform designed to meet customers wherever they are—whether they are individual consumers, corporate clients, or one-time buyers—and turn each interaction into a lasting relationship. By combining personalized guidance with technology, and over time AI-driven personalization and diagnostic insights, we intend to deliver a differentiated consumer health experience while building the predictable, recurring revenue that creates long-term value for our shareholders."

What the Numbers Show

The strategic shift toward a subscription model is underpinned by early operational data from the U.S. market. The platform builds on the subscription model launched for NOOR Collagen, which has delivered a repeat purchase rate above 60%. This metric indicates strong product-market fit and customer retention potential, providing a foundational proof point for scaling the broader platform across Cosmos Health’s portfolio of proprietary brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept, and C-Scrub.

Cosmos Health intends to expand the platform into international markets as part of its strategy to diversify revenue streams beyond traditional pharmaceutical distribution. The company, incorporated in Nevada in 2009, operates vertically integrated manufacturing facilities in the European Union through its subsidiary Cana Laboratories S.A., which is licensed under European Good Manufacturing Practices (GMP) and certified by the European Medicines Agency (EMA). The integration of digital subscription services complements its existing physical distribution network across Europe, Asia, and North America.

Cosmos Health Inc. has expanded its partnership with Pharma Cell for the distribution of its Sky Premium Life brand in Albania, projecting annualized orders to exceed 54,000 units. The expansion builds on the partnership the companies launched in April 2025, reflecting strong market reception. Average monthly orders have already exceeded 4,500 units, driven by recommendations from doctors and healthcare professionals across the country.

The products are distributed throughout Albania, supporting broad consumer access. Pharma Cell, based in Tirana, is a fast-growing pharmaceutical company specializing in high-quality food supplements. It operates an established distribution network serving pharmacies and healthcare professionals in the region.

Partnership Details

The expanded relationship underscores the momentum of Sky Premium Life's global growth. The following table outlines the key metrics associated with the partnership expansion:

Management Commentary

Greg Siokas, CEO of Cosmos Health, stated that the growth of the partnership reflects the strong momentum of Sky Premium Life in Albania. He noted that products are reaching a broad population, backed by recommendations from healthcare professionals. The company aims to continue growing the brand's presence in the market alongside Pharma Cell.